Option Care Health (OPCH) Stock Analysis & Winston Score
Option Care Health is one of the largest independent providers of home and alternate-site infusion therapy in the United States. The company delivers medications — like antibiotics, chemotherapy drugs, and nutrition treatments — directly to patients at home or at infusion clinics, instead of in a hospital. Its customers are patients with complex, chronic conditions, and it works closely with hospitals, physicians, and insurance companies to coordinate care. Option Care makes money by billing insurance companies, Medicare, and Medicaid for the drugs and nursing services it provides to patients. It operates across the U.S. through a network of over 100 infusion pharmacies and roughly 150 ambulatory infusion suites. Its scale and relationships with payers and health systems create a meaningful barrier for smaller competitors. The key growth driver is the ongoing shift of expensive infusion treatments out of hospitals and into lower-cost home settings, though reimbursement rate pressure from government and commercial payers remains a persistent risk.
Winston Score: 52/100 — Average
Mixed quality — meaningful strengths and weaknesses.
- Quality: Mixed (9/30)
- Growth: Good (11/20)
- Cash Flow: Strong (7/10)
- Stability: Good (6/10)
- Valuation: Strong (8/10)
- Ownership: Good (8/15)
Key Facts
Price: $23.70
Market Cap: $3.5B
Sector: Healthcare
Industry: Medical - Care Facilities
Exchange: NASDAQ

